A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO COMPARE THE EFFICACY AND SAFETY OF POMALIDOMIDE IN COMBINATION WITH LOW-DOSE DEXAMETHASONE VERSUS HIGH-DOSE DEXAMETHASONE IN SUBJECTS WITH REFRACTORY MULTIPLE MYELOMA OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA AND COMPANION STUDY: